X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Pills although so far the PBM has only dropped five drugs, targets could appear on the backs of other highly expensive drugs as reviews of products continues. (Photo: Getty)

Drugmakers, beware: if you boost the price on your products too much, a pharmacy benefit manager may just kick it off its list of approved formularies as the default option for doctors to prescribe.

Marlene Satter

Marlene Y. Satter has worked in and written about the financial industry for decades.

More from this author

BenefitsPRO

Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.